Equisul-SDT Oral Suspension
Equisul-SDT is an FDA-approved preparation containing Equisul-SDT, for veterinary use. Available by prescription.
Sulfadiazine (a sulfonamide antibiotic) and Trimethoprim (a dihydrofolate reductase inhibitor)
Veterinarians most commonly consider Equisul-SDT when a horse is presented with clinical signs of respiratory tract infections, particularly those involving Streptococcus equi subsp. zooepidemicus. It is frequently a point of discussion for managing localized tissue stress associated with skin and soft tissue infections or specific internal bacterial conditions. By utilizing a dual-pathway approach to inhibit bacterial growth, your veterinarian can manage the physiological environment of the patient during acute or chronic bacterial events.At a pharmacological level, the components of Equisul-SDT function through a sequential blockade of bacterial folic acid synthesis. Sulfadiazine acts as a competitive antagonist of para-aminobenzoic acid (PABA), which inhibits the initial production of dihydrofolate. Trimethoprim then binds to and reversibly inhibits the enzyme dihydrofolate reductase, blocking the subsequent conversion of dihydrofolate to tetrahydrofolate. Because bacteria require tetrahydrofolate for the synthesis of nucleic acids and proteins, this double blockade halts bacterial replication. The combination is considered bactericidal, whereas either component alone is typically bacteriostatic. Your veterinarian will determine whether Equisul-SDT is appropriate based on the horse's weight, clinical presentation and the results of diagnostic testing such as culture and sensitivity.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
Commonly observed effects of Equisul-SDT administration include localized gastrointestinal changes such as loose stools or a temporary decrease in appetite. Some horses may experience shifts in the digestive microbiome, which veterinarians monitor closely as a metabolic result of antimicrobial therapy. Owners should watch for signs of hypersensitivity, such as skin rashes or hives and report any behavioral changes or significant lethargy to their veterinarian. If you observe persistent diarrhea, physical distress or signs of an acute allergic reaction, contact your veterinarian promptly.
This medication is typically used with extra caution or avoided in horses with known hepatic or renal impairment or those with a history of blood dyscrasias. It is also carefully evaluated in breeding, pregnant or lactating mares, as the safety profile for developing foals is a point of ongoing clinical awareness. Before starting a protocol, ensure your veterinarian has a complete history of all other prescriptions and supplements your horse is receiving, as sulfonamides may interact with certain local anesthetics or other anti-folate medications. Your veterinarian is the right person to design a comprehensive monitoring plan and provide guidance on the necessary duration of use to ensure the management approach remains suitable for your horse's individual health status.
Yes. Equisul-SDT is an FDA-approved prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all authorizations before any medication is shipped to your stable.
While Equisul-SDT is a specific commercial oral suspension, Mixlab carries a full range of antimicrobial options. If your veterinarian determines that a different concentration or a flavored compounded alternative better suits your animal's individual needs, our compounding team can prepare a customized preparation with a valid prescription.
Owners should monitor for changes in manure consistency and appetite, as these are the most commonly observed physiological responses to oral antibiotics. It is important to report any signs of skin irritation or persistent digestive upset to your veterinarian to ensure the management plan remains appropriate.
Veterinarians frequently consider Equisul-SDT because its combination of sulfadiazine and trimethoprim provides a broad spectrum of activity against many common equine respiratory pathogens. Its liquid formulation is designed for ease of oral administration, allowing for consistent management of the bacterial load in the airway.
